Skip to main content
. 2017 Sep 18;8(49):85568–85583. doi: 10.18632/oncotarget.20996

Table 4. Comparison between PRMDA, MCMDA, HGIMDA and WBSMDA of the case studies.

Disease PRMDA MCMDA HGIMDA WBSMDA
Colon Neoplasms 46 42 45 45
Esophageal Neoplasms 47 31 44 29
Lymphoma 44 39 45 42

The second, third, fourth and fifth column record the number of verified miRNA-diseases associations among top 50 prioritized associations by PRMDA, MCMDA, HGIMDA and WBSMDA respectively.